A team of employees
in search of
innovative solutions
Our mission
Doxamed (formerly Loxamed) was born with the ambition of supporting populations with limited or non-existent access to care and medical treatment.
Innovation in healthcare at the heart of our DNA
Doxamed (formerly Loxamed) develops innovative healthcare services for local authorities and in sectors and activities that play a major role in people's lives: transport (notably with the SNCF and Air France groups), theme parks, construction sites, sports and cultural events.
Interview with the President of Doxamed (formerly Loxamed) by Dr Ludovic Toro, President of the Health and Solidarity Commission of the Greater Paris Metropolis.
Our history
Doxamed (formerly Loxamed) was born in March 2020 in a context of exceptional crisis, from an original idea by Arnaud Molinié, which became a reality thanks in particular to the support of Gérard Déprez, Chairman of the Loxam Group (No. 1 in Europe and No. 4 worldwide in equipment rental). Their common desire was to join forces in the face of the Covid-19 pandemic and make their contribution to the collective effort.
Initially, Doxamed (formerly Loxamed) used unused Loxam modules (due to construction stoppages) to install telemedicine devices (a nurse and connected objects) and offer screening, diagnosis and vaccination solutions, starting with the most vulnerable groups (the first installation was carried out in a migrant workers' hostel in the 19th arrondissement of Paris).
At the request of the Île-de-France Regional Health Agency (ARS), and in order to speed up screening and break the contamination chains, Doxamed (formerly Loxamed) quickly signed agreements with analysis laboratories (RTCPR tests) and pharmacies (antigenic tests). This system has been supported by the French government and local authorities.
Doxamed (formerly Loxamed) continued to develop innovative, connected mobile medical solutions in several major sectors of people's daily lives: transport (trains, stations, airplanes, airports), businesses (amusement parks, construction sites, shopping malls, offices, etc.), sports and cultural events (stadiums, championships, concert halls). Operations have been carried out in over 100 towns and 10 regions.
On January 13, 2025, Arnaud Molinié, Chairman of Capitello Med (Capitello Group's healthcare subsidiary) and Gérard Déprez, Chairman of Groupe Loxam, announced that they had reached an agreement under which their joint subsidiary, Loxamed, is now 100% owned by Capitello Med, which previously held 49%. Following this acquisition, Capitello Med has renamed the subsidiary Doxamed.
Foyer de la Commanderie (Paris XIXe)
Doxamed (formerly Loxamed) wins the 2022 Territorial Innovation Award
Doxamed (formerly Loxamed) was awarded the Territorial Innovation prize - in the Territorial Development & Management category - for "the deployment of customized, assisted and connected telemedicine projects, responding to the issues of medical desertification and access to diagnosis and care".
From left to right: Matthieu Guillotin, Managing Director of Doxamed (formerly Loxamed); Arnaud Molinié, President of Doxamed (formerly Loxamed); Murielle Fabre, Secretary General of the Association des Maires de France; and Stéphanie Gay-Torrente, Director of the Salons et Congrès Collectivités et Immobilier - Infopro Digital division. Doxamed (ex Loxamed)
Our latest publications
-
Reinforcing healthcare systems, particularly in medical deserts -
A new initiative for occupational health in France 5/02/2025 -
Tailor-made: within your PN city, open 24/7 and complementing your occupational medicine. -
Drawing on our experience and know-how in dealing with epidemic peaks, we can offer you turnkey, tailor-made solutions for Covid-19 and/or influenza vaccinations to help protect your employees. -
Doxamed (formerly Loxamed) supports local authorities, companies and "major events" at every stage (consulting/engineering/implementation) of the medical project, by integrating and bringing together all the stakeholders in the ecosystem. The patient, at the heart of the system, is assisted by an on-site healthcare professional. -
PREVENTION, SCREENING, TELEMEDICINE: HEALTH ENTERS THE STATION Aware that local healthcare coverage is a national priority, SNCF Gares SNCF Gares & Connexions has decided to make it easier and faster to provide in stations. On Monday November 13, the sole manager of 3,000 railway stations signed a promise Temporary Occupancy Agreement (COT) with Doxamed (formerly Loxamed) concerning the ability to the ability to deploy a new healthcare offering in railway stations, according to the a new healthcare offering in nearly 300 stations by 2028. The aim is to facilitate access to healthcare for French people in areas with insufficient medical coverage. medical coverage. -
From consultancy to the implementation of a medical project, Doxamed (formerly Loxamed) has developed a territorial healthcare organization and cooperation approach that facilitates and improves the healthcare pathway for people with difficulties accessing care. -
Doxamed (formerly Loxamed) can help you set up prevention and telemedicine systems in mobile medical vehicles or in premises made available by local authorities. -
In an environment exposed to health risks and marked by difficulties of access to healthcare, the company has a key role to play with its employees. Doxamed (formerly Loxamed) develops awareness-raising, screening, vaccination and teleconsultation programs that mobilize its medical department and its network of partners (healthcare professionals, laboratories, etc.). -
This book brings together numerous contributions from players in the healthcare and political sectors, as well as from members of civil society. Essential testimonials and invaluable experiences to nourish the framework of tomorrow's public health policy. Enriched by a first part giving the main benchmarks for healthcare provision in France and internationally, this white paper also features an exclusive survey on "The French and equal access to healthcare". -
Combating medical deserts, even in white zones Doxamed (formerly Loxamed) supports local authorities at every stage in the implementation of a medical project. From consulting to implementation, Doxamed (formerly Loxamed) has developed a territorial health organization and cooperation approach that facilitates and improves the healthcare pathway for people with difficulties accessing care. Doxamed (formerly Loxamed) integrates and brings together all the stakeholders in the ecosystem: healthcare professionals and territorial organizations such as the CPTS, elected representatives, the Region, EPCIs, Departmental Councils, the ARS, the DCGDR and the Caisses d'Assurance Maladie. -
Doxamed (formerly Loxamed) offers a service for anyone who has completed a full course of vaccinations outside a country that issues vaccination certificates in the European format, to convert their original vaccination pass into a European pass. This equivalence is compulsory for residents of many countries1. In order to be authorized to enter France and the majority of European countries, French nationals living abroad must now obtain an equivalent European pass. -
In this period of record epidemic resurgence, the town of Le Chesnay-Rocquencourt has made every effort to ensure the safety of its residents and visitors to the Westfield Parly 2 shopping center in the commune. In partnership with Doxamed (formerly Loxamed) and Cerballiance laboratories, and with financial support from the Ile-de-France region, the town decided to install an RT-PCR screening system at the heart of the Westfield Parly 2 shopping center, which receives over 12 million visits a year. -
Against a backdrop of intense spread of the virus, and in order to meet the high demand for screening, the city of Versailles has called on Doxamed (formerly Loxamed) to deploy a mobile, operational covid test system in the heart of the town, for the benefit of all residents. -
Doxamed (formerly Loxamed) supports ski resorts by installing a COVID screening system at ChamrousseDoxamed (ex Loxamed) installs a screening facility at the heart of the Chamrousse ski resort, reinforcing the town's health resources during this period of high tourist attraction. Against a backdrop of strong pandemic resurgence, ski resorts are preparing to enter the busiest tourist season of the year. They are faced with the need to strengthen their medical resources to meet the very high demand for screening. -
Doxamed (formerly Loxamed), a company specializing in mobility and medical technology, has developed a Health Hub with the town of Louveciennes. Within this Hub, healthcare professionals offer RT-PCR tests, antigenic tests and teleconsultation. Doxamed (formerly Loxamed) also supports pharmacies as part of the vaccination campaign, with the help of the town council. -
Doxamed (ex Loxamed), a company specializing in mobility and medical technology, will be taking part in the Salon des Maires, from November 16 to 18, 2021. A stand dedicated to the company will be set up in pavilion 2.2. Health-related issues will be at the heart of the show. The health inequalities revealed during the pandemic, the issue of medical deserts and access to care, are essential and urgent challenges for municipalities and local authorities. -
Doxamed (formerly Loxamed), a company specializing in medical mobility, has been present since the beginning of the health crisis, deploying high-performance screening and telemedicine solutions throughout the country, in stations, stadiums, amusement parks, local authorities and businesses, in the form of mobile boxes, mobile trucks or solid installations. -
Since Monday August 9, Doxamed (formerly Loxamed) has been present at 11 new railway stations, including Metz Ville, Nancy, Paris Montparnasse 1 and 2, Strasbourg, Le Mans and Toulouse, offering Covid antigenic screening to make the summer period even safer, and to facilitate the implementation of the health pass in transport. -
Following the French President's statements on July 12, announcing the implementation of the health pass in leisure and cultural venues, Parc Asterix (Oise), in partnership with LOXAMED, has decided to install, at the park entrance and from July 21, 2021, a specific screening device, with the aim of securing and facilitating access to the park for future visitors. -
In collaboration with the town of La Baule, and as an extension of its national partnership with SNCF Gares & Connexions, Doxamed (formerly Loxamed) is installing an RT-PCR screening booth on the forecourt of La Baule-Escoublac station, for use by summer holidaymakers, especially young people. -
Doxamed (formerly Loxamed) is recruiting a senior advisor with a proven track record in the hotel and catering industry to help develop and adapt its solutions for the tourism industry. -
Doxamed (formerly Loxamed) has built a fully customized RT-PCR screening system for its customer Air France, in partnership with Unilabs France laboratories. -
After Paris Gare de Lyon, Paris-Est, Marseille Saint-Charles, Bordeaux Saint-Jean, Nice Ville Ville, Rennes and Grenoble, Doxamed (formerly Loxamed) has moved to the Havre forecourt of Gare Saint-Lazare to testing capacities in Paris, and to experiment with saliva sampling with its partner partner Unilabs France. -
After installing a screening BOX on the forecourt of the Nice Ville train station on March 1 to facilitate access to tests, Doxamed (formerly Loxamed) is now deploying a "MobilVaccin" BOX on the same forecourt to boost the vaccination capacity of the Nice Côte d'Azur metropolitan area. -
Since the start of the pandemic, Doxamed (formerly Loxamed), a company specializing in medical mobility, has been fully committed to the national health security policy, with a particular focus on supporting isolated areas with saturated or non-existent medical services. -
Since the beginning of February, Doxamed (formerly Loxamed) has set up modular boxes in 5 vaccinodromes in Belgium, in order to participate more widely in the fight against Covid-19. -
Doxamed (formerly Loxamed) has been the health partner of the French Rubgy Federation since the beginning of the health crisis. It ensures the safety of events and of men's and women's teams in the face of the Covid. -
To cope with the influx of screening requests, to be present in the vaccination phase and to anticipate tomorrow's changes, Arnaud Molinié, Chairman of LOXAMED, in agreement with Gérard Deprez, Chairman of Loxam, has decided to further strengthen and structure LOXAMED's executive team by appointing Matthieu Guillotin, Sales Director with expertise in mobility. Olivier Falque, a Loxam employee for almost 20 years, also joins the LOXAMED teams to bring his logistics expertise as Operations Manager. -
As part of the major screening campaign launched by the Ile-de-France region, L'Etang-la-Ville town hall is stepping up its participation in the national effort by opening a MobilTest Doxamed (formerly Loxamed) box to all Stagnovillois and residents of surrounding towns on Monday November 23 in the Val d'Argent market square. -
To reinforce its nationwide COVID-19 screening campaign, SNCF Gares & Connexions has responded favorably to Doxamed (formerly Loxamed), a medical mobility company, for the installation of 5 booths on station forecourts. After Paris gare de Lyon and the stations of Paris-Est, Marseille Saint-Charles and Bordeaux Saint-Jean, a mobile COVID screening unit is now opening on the southern forecourt of Rennes station. -
To reinforce the national mobilization for COVID-19 screening, SNCF Gares & Connexions has responded favorably to Doxamed (ex Loxamed), a medical mobility company, for the installation of 5 screening units on the forecourts of several stations. After two Paris stations on November 5, mobile COVID screening units will open this Thursday November 12 on the forecourts of Marseille Saint-Charles and Bordeaux Saint-Jean stations. -
In order to reinforce the national COVID-19 screening campaign, SNCF Gares & Connexions has responded favorably to Doxamed (ex Loxamed), a medical mobility company, for the installation of 5 booths on station forecourts. COVID mobile screening units are opening today on the forecourts of Marseille Saint-Charles and Bordeaux Saint-Jean stations, following the deployment of the first two boxes in front of Paris Gare de Lyon and Paris-Est stations on November 5. A fifth box will soon be installed near Rennes station. -
In order to reinforce the national COVID-19 screening campaign, SNCF Gares & Connexions has responded favorably to Doxamed (ex Loxamed), a medical mobility company, for the installation of 5 booths on station forecourts. COVID mobile screening units are opening today on the forecourts of Bordeaux Saint-Jean and Marseille Saint-Charles stations, following the deployment of the first two boxes in front of Paris Gare de Lyon and Paris-Est stations on November 5. A fifth box will soon be installed near Rennes station. -
To reinforce the national mobilization for COVID-19 screening, SNCF Gares & Connexions has responded favorably to Doxamed (ex Loxamed), a medical mobility company, for the installation of to install 5 booths on station forecourts. Mobile COVID screening units will be installed on November 5 in front of Paris Gare de Lyon and Paris Est stations. The station forecourts at Marseille Saint-Charles and Bordeaux Saint-Jean, followed by Rennes, will soon be equipped with screening booths. -
On the occasion of the inauguration of the "We love 2023" train, deployed by SNCF as part of the Rugby World Cup 2023, Doxamed (ex Loxamed) presented its Covid Covid test and diagnostic unit, which will be installed in one of the train's carriages. During her visit to the train, the Mayor of Paris, Anne Hidalgo, underlined "the effectiveness of the Doxamed (ex Loxamed) system", which she tested in the 19th arrondissement of Paris, as part of a screening program for migrant workers. -
Doxamed (formerly Loxamed) has been chosen by the Ile-de-France region to reinforce its screening policy and make it accessible to all Ile-de-France residents. The Ile-de-France region is facing a deteriorating health situation in its eight departments. An effective screening policy is an essential means of containing the circulation and spread of the virus. -
At a time when new outbreaks of contamination are raising fears of a resumption of the COVID-19 epidemic, the Agence Régionale de Santé (ARS) Ile-de-France has issued a favorable opinion on LOXAMED's Mobile Diagnostic and Screening Unit, which will reinforce the control and fight against the epidemic. -
Olympique Lyonnais would like to inform you that it will be resuming its activities on Monday June 8, within a very strict sanitary framework and with respect for the protection of employees' health, which is an absolute priority. The epidemic remains active and the virus is still circulating; it is everyone's responsibility to remain cautious and respect all barrier measures. -
For over 15 days, a pilot mobile diagnostic and screening unit (UMDD) has been installed in front of a migrant workers' hostel in the 19th arrondissement. This innovative device, devised by LOXAM in partnership with AXAMED laboratories and the TELEDOK medical platform, will be deployed, at the request of the City of Paris, in all the capital's arrondissements to meet the needs of the city and its residents during the decontamination period.
